Discontinued — last reported Q4 '25

Other Income & Expense

Other Income (Expense)

Eli Lilly Other Income (Expense) increased by 40.0% to -$65.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 72.8%, from -$239.00M to -$65.00M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 41.5% CAGR.

Analysis

StatementIncome Statement
SectionOther Income & Expense
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

Significant fluctuations often relate to changes in interest rates, investment valuations, or currency volatility.

Detailed definition

The net total of income and expenses from non-operating activities, such as interest income, interest expense, and gains...

Peer comparison

Companies with large cash piles often show significant interest income here, while highly levered firms show interest expense.

Metric ID: other_income_expense_net

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$190.50M-$635.90M-$77.30M-$350.70M-$119.20M-$111.00M$35.70M-$36.80M-$23.20M$121.00M$27.10M-$197.60M$62.00M-$110.10M-$239.00M-$90.60M-$133.10M-$108.30M-$65.00M
QoQ Change-433.8%+87.8%-353.7%+66.0%+6.9%+132.2%-203.1%+37.0%+621.6%-77.6%-829.2%+131.4%-277.6%-117.1%+62.1%-46.9%+18.6%+40.0%
YoY Change-162.6%+82.5%+110.2%+69.1%+79.1%-24.1%-437.0%+367.2%-191.0%-981.9%+54.1%-314.7%+1.6%+72.8%
Range-$635.90M$190.50M
CAGR-21.3%
Avg YoY Growth-91.0%
Median YoY Growth+27.9%
Current Streak2 quarters growth

Frequently Asked Questions

What is Eli Lilly's other income (expense)?
Eli Lilly (LLY) reported other income (expense) of -$65.00M in Q1 2026.
How has Eli Lilly's other income (expense) changed year-over-year?
Eli Lilly's other income (expense) increased by 72.8% year-over-year, from -$239.00M to -$65.00M.
What is the long-term trend for Eli Lilly's other income (expense)?
Over 3 years (2021 to 2025), Eli Lilly's other income (expense) has grown at a 41.5% compound annual growth rate (CAGR), from -$201.60M to -$571.00M.
What does other income (expense) mean?
Money made or lost from activities not related to the company's main business, like investments or interest.